Genuity Capital Markets
http://www.genuitycm.com/Genuity Capital Markets is a financial services firm providing investment banking, institutional sales and trading, and equity research to its corporate clients. The firm uses a simple Buy, Hold and Sell rating system in its research analysis.
View Older Stories View More Recent Stories
-
UPDATE - Canaccord Genuity Initiates Coverage on Newpark Resources (NR) with a Hold; A Lot Going For It, But Shares Up 36% YTD
-
GI Dynamics to Present at Canaccord Genuity 6th Annual Cardiovascular, Aesthetics & Metabolic Disorders Conference
-
DUSA Pharmaceuticals to Present at the Canaccord Genuity 6th Annual Cardiovascular, Aesthetics & Metabolic Disorders Conference
-
Cynosure to Present at Canaccord Genuity 6th Annual Cardiovascular, Aesthetics & Metabolic Disorders Conference
-
Canaccord Genuity Reiterates a 'Buy' on ArthroCare (ARTC); Second Legal Overhang Removed, Only DOJ Remains; Expect Stock to Trade Up
-
Canaccord Genuity Maintains a 'Sell' on Netflix (NFLX); No Surprises On The Capital Raise, Other Than The Amount
-
Canaccord Genuity Maintains a 'Buy' on Chesapeake Energy (CHK); Management Meeting Gives Greater Comfort in Ability to Meet Liquidity Goals
-
EnteroMedics to Present at the Canaccord Genuity Sixth Annual Cardiovascular, Aesthetics and Metabolic Disorders Conference
-
Canaccord Genuity Starts Newpark Resources (NR) at Hold
-
Urologix to Present at the Canaccord Genuity 6th Annual Cardiovascular, Aesthetics and Metabolic Disorders Conference
-
Shares of Agnico-Eagle Mines (AEM) Sink on Downgrade
-
Notable Analyst Rating Changes 11/28: (NFLX) (GNW) (ERTS) Upgraded; (C) (MOS) (K) Downgraded
-
Canaccord Genuity Maintains a 'Buy' on AVEO Pharmaceuticals (AVEO); ODAC Vote Could Shape Future RCC Treatment Landscape
-
Canaccord Genuity on Specialty Pharmaceuticals: Gx Lipitor - Broad Implications but Focus on Expectations
-
Canaccord Genuity Reiterates a 'Buy' on Cadence Pharma (CADX); Encouraging October Ofirmev RX Trends, Stronger Balance Sheet
-
Canaccord Genuity Reiterates a 'Buy' on Spreadtrum Communications (SPRD); Upbeat Management Meetings; 2012 Roadmap Drives Growth
-
Canaccord Genuity Reiterates a 'Buy' on Qualcomm (QCOM); HTC Weakness Company-Specific Versus Smartphone Macro Weakness
-
Galane Gold Ltd. Reports Third Quarter Results
-
Galane Gold Ltd. Reports Third Quarter Results
-
Canaccord Genuity Downgrades Mosaic (MOS) to Hold
-
Canaccord Genuity Downgrades Agnico-Eagle Mines Ltd. (AEM) to Hold
-
Solium Capital Inc. Announces Notice of Intention to Make a Normal Course Issuer Bid
-
Guerrero Announces First Closing of Financing
-
Guerrero Announces First Closing of Financing
-
ExactTarget Files Registration Statement for Proposed Initial Public Offering
-
ExactTarget Files $100M IPO
-
Canaccord Genuity Morning Coffee on Warren Buffett: Even Buffett Has His Mystery Stocks
-
Canaccord Genuity Morning Coffee on Federal Open Market Committee Minutes: Mo Minutes, Mo Minutes, Mo...
-
Canaccord Genuity on Life Sciences/Specialty Pharma: Columbia Labs Management Call - PROCHIEVE Update with Implications for BUY-rated Watson (WPI)
-
Canaccord Genuity Reiterates a 'Buy' on Nuance Communications (NUAN); Good Guidance Likely Means Now Higher Multiple Sustainable
-
Thoratec Announces Presentations at Upcoming Investor Conferences
-
Fibrocell Science, Inc. to Present at the Canaccord Genuity 6th Annual Cardiovascular, Aesthetics and Metabolic Disorders Conference
-
Cutera to Present at the Canaccord Genuity 6th Annual Cardiovascular, Aesthetics and Metabolic Disorders Conference
-
Canaccord Genuity Morning Coffee on Budget Super Committee: Sequestration or Automatic Spending Cuts
-
Canaccord Genuity Reiterates a 'Buy' on Inhibitex (INHX); Acquisition Validates Nuc Prodrug Promise
-
Canaccord Genuity Maintains a 'Speculative Buy' on Delcath Systems (DCTH); First Commercial Center on Board
-
Canaccord Genuity Downgrades Pharmasset (VRUS) to 'Hold' Following Announced Acquisition
-
Canaccord Genuity Maintains a 'Buy' on Cree (CREE); Takeaways Post Management Meeting
-
Canaccord Genuity Reiterates a 'Buy' on 3D Systems (DDD); Prices Convert To Expand Opportunity With Meaningful Acquisition
-
Canaccord Genuity Maintains a 'Buy' on Analog Devices (ADI); Expecting JanQ To Be The Bottom
-
Canaccord Genuity Re-Initiates Coverage on Netflix (NFLX) at Sell; Positive Macro Outweighed by Numerous Company-Specific Issues
-
Volcano Corporation Announces Presentations at Upcoming Investor Conferences
-
Maple Leaf Short Duration 2011-II Flow-Through Limited Partnership: Offering Closed, $15,876,750 Raised
-
Maple Leaf Short Duration 2011-II Flow-Through Limited Partnership: Offering Closed, $15,876,750 Raised
-
Canaccord Genuity Morning Coffee on Budget Super Committee: Set to Fail?
-
Canaccord Genuity on Pharmasset (VRUS): Acquisition Validates Power of Nuc Prodrugs
-
3D Systems Announces Pricing of $152 Million of 5.50% Senior Convertible Notes Due 2016
-
Endologix to Present at Three Upcoming Investor Conferences
-
Canaccord Genuity Reiterates a 'Hold' on Vertex (VRTX); Continued View of Challenging Out-Year Competitive Landscape
-
Canaccord Genuity Maintains a 'Hold' on Impax Laboratories (IPXL); Deep Discount Deeper and Near-Term Headwinds Nearer -- Risk/Reward Improving
